Screening of silent inflammatory bowel disease in seronegative spondyloarthritis patients: Fecal calprotectin, ileo-colonoscopy and histopathology assessment

Shaimaa Badran; Andrew Saweres; Hadeel GamalEldeen; Mohamed B. Hashem; Dalia Abdel-kareem; Fatma H. Abdelraouf; Wafaa Gaber; Tamer Elbaz

doi:10.1016/j.ejr.2023.10.001

Q3 2024

Screening of silent inflammatory bowel disease in seronegative spondyloarthritis patients: Fecal calprotectin, ileo-colonoscopy and histopathology assessment

Shaimaa Badran · Andrew Saweres · Hadeel GamalEldeen · Mohamed B. Hashem · Dalia Abdel-kareem · Fatma H. Abdelraouf · Wafaa Gaber · Tamer Elbaz

10.1016/j.ejr.2023.10.001 392 Views 4 Citations

Citations

392

Views

Abstract not available for this publication.

Cite this Article (APA)

Shaimaa, B., Andrew, S., Hadeel, G., Mohamed, B. H., Dalia, A., Fatma, H. A., Wafaa, G., Tamer, E. (2024). Screening of silent inflammatory bowel disease in seronegative spondyloarthritis patients: Fecal calprotectin, ileo-colonoscopy and histopathology assessment. Egyptian Rheumatologist. https://doi.org/10.1016/j.ejr.2023.10.001